Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.635 USD | -4.97% | -16.15% | -33.16% |
05-16 | Replimune Group, Inc. Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
04-08 | Replimune Group Provides Interim Results for Skin Cancer Therapy | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.16% | 364M | |
+64.78% | 62.59B | |
-2.07% | 41.18B | |
+44.76% | 40.29B | |
-8.93% | 27.9B | |
+12.33% | 26.21B | |
-21.83% | 19.09B | |
+3.73% | 13.08B | |
+25.61% | 12.26B | |
+27.19% | 12.05B |
- Stock Market
- Equities
- REPL Stock
- News Replimune Group, Inc.
- Insider Trends: Replimune Group Insider Continues 90-Day Selling Trend